Stay updated on ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Sign up to get notified when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.

Latest updates to the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe record history adds a new revision entry v3.6.5 and removes the previous v3.6.4 entry, reflecting an update to the page's revision history.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe history now shows a new site revision (v3.6.4) replacing the previous revision (v3.6.3), indicating a recent software release for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check46 days agoChange DetectedA new Study Status entry was added to the record history (noted on 2026-07-02 with 120 items) and an older entry dated 2026-06-05 was removed. This updates the visible history of the trial’s status and its historical record.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history now shows the page revision updated to v3.6.3, replacing the previous v3.6.2, reflecting an underlying platform update rather than changes to study content.SummaryDifference0.0%

- Check60 days agoChange DetectedFooter now displays Revision: v3.6.2, replacing v3.6.0. This indicates a recent software update applied to the page.SummaryDifference0.0%

- Check74 days agoChange DetectedOne addition indicates the study is no longer looking for participants, signaling that recruitment has ceased. The record history also shows a new revision tag v3.6.0 and the removal of the previous v3.5.5 revision, reflecting an update to the study documentation.SummaryDifference0.1%

Stay in the know with updates to ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ATLAS Clinical Trial: Apalutamide in High-risk Prostate Cancer page.